SCHEMBL31423911

SCHEMBL31423911

CC(C)Oc1c(-c2cn[nH]c2)ncn2nc(N[C@H]3CC[C@@H]3C(F)(F)F)nc12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423950 1.00 ATR (0.32) ATR
SCHEMBL31423921 0.91
SCHEMBL31423891 0.91
SCHEMBL25277898 0.83 ATR (0.35) ATR
SCHEMBL23209448 0.82 FLT3 (0.32) ATR
SCHEMBL31423979 0.82 JAK2 (0.37)
SCHEMBL31318288 0.82 MAPK8 (0.41) ATR
Hydrochloric Acid SCHEMBL23209481 0.82 FLT3 (0.32) ATR
SCHEMBL31423875 0.81 ATR (0.35) ATR
SCHEMBL31423883 0.81 MAPK8 (0.33) ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054386-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed